AHF Backs FTC Challenge to Big Pharma Junk Patents

AHF Backs FTC Challenge to Big Pharma Junk Patents

Business Wire

Published

LOS ANGELES--(BUSINESS WIRE)-- #BigPharma--AIDS Healthcare Foundation (AHF) voiced support for the U.S. Federal Trade Commission (FTC) taking action this week to challenge several major pharmaceutical companies, including GSK, for anticompetitive use of so-called junk patents that prevent generic competition and keep drug prices artificially high. “Big pharma is abusing the patent system by filing multiple derivative patents on existing drugs – which is not innovation – it’s greed. They pull every trick in

Full Article